Nature Search

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population

Evelyn R. Brandt
K.S. Sriprakash
Michael F. Good
Research01 Apr 2000
Nature Medicine

Volume: 6, P: 455-459
Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial

Evidence for the treatment of patients with mild-to-moderate COPD is limited. Here, the authors show that long-term treatment with high-dose N-acetylcysteine neither significantly reduced the annual rate of total exacerbations nor improve lung function in patients with mild-tomoderate COPD.

Yumin Zhou
Fan Wu
Li Chen
ResearchOpen Access30 Sept 2024
Nature Communications

Volume: 15, P: 1-11
Enabling robust blue circularly polarized organic afterglow through self-confining isolated chiral chromophore

The preparation of systems that give blue circularly polarised organic afterglow is desirable but challenging. Here, the authors confine a chiral chromophore within a polymer matrix to limit non-radiative transitions and give blue circularly polarised organic afterglow.

Mingjian Zeng
Weiguang Wang
Wei Huang
ResearchOpen Access09 Apr 2024
Nature Communications

Volume: 15, P: 1-10
Human CD8⁺ T cell cross-reactivity across influenza A, B and C viruses

Cross-protective responses across all strains of influenza virus (IAV, IBV and ICV) are a key goal of universal vaccines against influenza. Kedzierska and colleagues identify cytotoxic T cells present in blood and lungs of healthy people that are directed against all strains of influenza virus.

Marios Koutsakos
Patricia T. Illing
Katherine Kedzierska
Research18 Feb 2019
Nature Immunology

Volume: 20, P: 613-625
Universal in situ supersaturated crystallization enables 3D printable afterglow hydrogel

Shuman Zhang
Yunliang Ji
Wei Huang
ResearchOpen Access01 Feb 2025
npj Flexible Electronics

Volume: 9, P: 1-10
A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host

Pradeep K Rai
Sathi Babu Chodisetti
Javed N Agrewala
ResearchOpen Access07 Apr 2016
Scientific Reports

Volume: 6, P: 1-11
A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity

Hongbo Chen
Xiaobin Zeng
Lin Mei
ResearchOpen Access04 Jun 2015
Scientific Reports

Volume: 5, P: 1-15

Search

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population

Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial

Enabling robust blue circularly polarized organic afterglow through self-confining isolated chiral chromophore

Human CD8⁺ T cell cross-reactivity across influenza A, B and C viruses

Universal in situ supersaturated crystallization enables 3D printable afterglow hydrogel

A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host

A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity

Search

Quick links

Search

Filter By:

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population

Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial

Enabling robust blue circularly polarized organic afterglow through self-confining isolated chiral chromophore

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

Universal in situ supersaturated crystallization enables 3D printable afterglow hydrogel

A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host

A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity

Search

Quick links

Human CD8⁺ T cell cross-reactivity across influenza A, B and C viruses